about
Zika virus: An update on epidemiology, pathology, molecular biology, and animal modelZika virus update II: Recent development of animal models - proofs of association with human pathogenesisKaposi's sarcoma-associated herpesvirus induction of AP-1 and interleukin 6 during primary infection mediated by multiple mitogen-activated protein kinase pathways.Kaposi's sarcoma-associated herpesvirus induces rapid release of angiopoietin-2 from endothelial cellsIdentification of a novel cellular transcriptional repressor interacting with the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirusActin dynamics regulate multiple endosomal steps during Kaposi's sarcoma-associated herpesvirus entry and trafficking in endothelial cellsThe ubiquitin/proteasome system mediates entry and endosomal trafficking of Kaposi's sarcoma-associated herpesvirus in endothelial cellsKSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcomaOncogenic herpesvirus KSHV Hijacks BMP-Smad1-Id signaling to promote tumorigenesisIdentification and Function of MicroRNAs Encoded by HerpesvirusesAngiogenesis, Kaposi's Sarcoma and Kaposi's Sarcoma-Associated HerpesvirusSeroprevalence of Kaposi's sarcoma-associated herpesvirus and risk factors in Xinjiang, ChinaThe SH3BGR/STAT3 Pathway Regulates Cell Migration and Angiogenesis Induced by a Gammaherpesvirus MicroRNA.Accurate LC peak boundary detection for ¹⁶O/¹⁸O labeled LC-MS dataRecurrent genomic imbalances in primary effusion lymphomas.Increased tumorigenicity of cells carrying recombinant human herpesvirus 8.The association of neoplasms and HIV infection in the correctional settingEarly and sustained expression of latent and host modulating genes in coordinated transcriptional program of KSHV productive primary infection of human primary endothelial cells.Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNACancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2.Autoexcision of bacterial artificial chromosome facilitated by terminal repeat-mediated homologous recombination: a novel approach for generating traceless genetic mutants of herpesvirusesImproving performance of mammalian microRNA target prediction.Robust inference of the context specific structure and temporal dynamics of gene regulatory networkA Bayesian approach for identifying miRNA targets by combining sequence prediction and gene expression profiling.Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latencyKaposi's sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replicationViral miRNA targeting of bicistronic and polycistronic transcriptsHIV-1 Nef and KSHV oncogene K1 synergistically promote angiogenesis by inducing cellular miR-718 to regulate the PTEN/AKT/mTOR signaling pathway.Exploitation of the complement system by oncogenic Kaposi's sarcoma-associated herpesvirus for cell survival and persistent infectionRhesus rhadinovirus infection of rhesus fibroblasts occurs through clathrin-mediated endocytosis.Regulation of herpesvirus lifecycle by viral microRNAs.HIV-1 Tat promotes Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6-induced angiogenesis and tumorigenesis by regulating PI3K/PTEN/AKT/GSK-3β signaling pathwayViruses and human cancer: from detection to causality.Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapyAcetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription.Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and ReactivationRecent advances in cloning herpesviral genomes as infectious bacterial artificial chromosomesKSHV microRNAs mediate cellular transformation and tumorigenesis by redundantly targeting cell growth and survival pathwaysFunctional characterization of Kaposi's sarcoma-associated herpesvirus ORF45 by bacterial artificial chromosome-based mutagenesis.
P50
Q24244835-A1E24328-F230-4FC4-B691-A796902EF9FFQ24276745-07688722-E302-4795-9DD6-16E99A097F26Q24534690-5748954A-2A86-4C23-88CB-D3773756424EQ24629364-B6552447-29FA-4B99-B41D-B57286618321Q24646461-4F09AA4A-8A66-47B3-99E4-38F4AA4CF345Q27316598-37FCA6F6-B446-4644-9867-A10801AA9A8BQ27345534-534C390D-9664-4D0A-93BF-5F471ADC7815Q28284765-E4DE0A1A-F66C-4827-A9D6-DEB5946352F1Q28540651-A299C4CE-72C4-4764-952C-C4DE489BBA2FQ28749288-0E5D58E3-B790-457F-872E-0A950F01CA90Q28750291-4129D5BE-748F-4643-826E-01DA83BA7DDCQ28750969-124FAC77-3031-42D6-9716-4D130D9E5788Q30008930-1293E472-42D5-48B1-A9DF-AE2E13400F1BQ30675913-2C6FB706-864C-4CED-9EC7-C77BE037E057Q33562285-8427EBFF-EF53-413E-A062-4B7382E3F8BCQ33585787-841B0BC3-E46F-4620-9581-1574E837643BQ33610431-609DE6F8-89A7-46F2-ABED-F85F7DF4ED4CQ33623056-85ABC4A7-85F4-4064-AFB6-F683F4FFB195Q33625562-22A845F7-2ED9-448E-8EA7-6DB8A72C3DF7Q33667093-82EF7846-5AEE-4D78-97DE-F05ADC401D71Q33676526-2E121834-8A3C-438A-8408-F7177B6B7B74Q33699424-C0289722-3C9B-4205-8027-41F1E3DFD2E6Q33766577-BCA66619-448B-44AE-B62D-1D384D142ACEQ33766581-41652C45-ADFA-404C-9050-75C720600D38Q33887681-F1F6530A-2FFA-41C6-8CD5-1ABB92802D40Q33916507-6C70AACA-235B-4F1B-A276-116F7210B724Q34059252-06508C2E-977D-4462-8EB4-F98973B6C1A8Q34112086-2E96C5B0-6AA3-4821-B37B-A8CEB77601F8Q34115364-CF6C39EF-D5CD-4803-9196-900EC5F4F1FAQ34257818-F0BB178A-CF5E-452D-8A3A-69D2C25522ACQ34296031-9FFD9EDC-954D-4C65-996F-8D041ACA30A1Q34412460-5A0C0CA0-7A9D-4231-8DE2-9B0721DD0A4DQ34542341-EF48239B-CC48-4871-8228-413F574724BCQ34567612-65FAF48A-F188-4ABA-A0AB-9C997041BBEDQ34635757-34A5E19B-D9D9-49AB-8402-3D2468D7F779Q34648229-6FCC5A80-A73F-4B5F-93AC-2F34E40B1311Q35010647-9F8F4542-5AD0-4388-B262-C9F69A0CD304Q35045319-A414FC50-C685-4283-92B0-3539572B3CEAQ35079842-3A22F22F-01C3-4F84-B2D6-286730AB1FDAQ35185925-F9232CAC-01D6-4FF0-BCBE-FC83F43A0876
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Shou-Jiang Gao
@ast
Shou-Jiang Gao
@en
Shou-Jiang Gao
@es
Shou-Jiang Gao
@nl
Shou-Jiang Gao
@sl
type
label
Shou-Jiang Gao
@ast
Shou-Jiang Gao
@en
Shou-Jiang Gao
@es
Shou-Jiang Gao
@nl
Shou-Jiang Gao
@sl
prefLabel
Shou-Jiang Gao
@ast
Shou-Jiang Gao
@en
Shou-Jiang Gao
@es
Shou-Jiang Gao
@nl
Shou-Jiang Gao
@sl
P106
P1153
7403257411
P31
P496
0000-0001-6194-1742